Gender (n=161) | Male | 120 | 74.5% | |
Female | 41 | 25.5% | |
Age(Mean, 95% CI) (n = 161) | 64. 6 ± 10.1 | Lower: 62.90 | Upper: 66.31 |
American Society of Anesthesiology score (ASA) (n = 161) | 1 | 53 | 32.9% | |
2 | 83 | 51.6% | |
3 | 25 | 15.5% | |
Type of resection (n=161) | Distal esophagectomy and total gastrectomy | 136 | 84.5% | |
Distal esophagectomy and proximal gastrectomy | 25 | 15.5% | |
Extend of lymphadenectomy (n = 161) | D1 | 19 | 11.8% | |
D2 | 142 | 88.2% | |
Metastatic lymph nodes(mean, 95% CI) (n = 161) | 6.11 ± 7.7 | Lower: 4.91 | Upper: 7.32 |
All harvested lymph nodes(mean, 95% CI) (n = 161) | 23.20 ± 11.7 | 21.37 | 25.03 |
Splenectomy (n = 161) | 76 | 47.2% | |
Additional oncological resections | 20 | 12.4% | |
R0 resection | 154 | 95.7% | |
Proximal resection margin in mm(mean, 95% CI) (n = 142) | 42.45 ± 20.7 | Lower: 39.0 | Upper: 45.80 |
Proximal resection margin < 20 mm (in fixed specimen + 0,9cm stapler ring) (n = 142) | 9 | 5.6% | |
Diameter of the tumor in mm(mean, 95% CI) (n = 161) | 63.16 ± 23.1 | Lower: 58.18 | Upper: 68.15 |
Any type of oncological treatment completed | 56 | 34.8% | |